Health product recall

Contrave Tablet (Extended Release) (2018-08-06)

Starting date:
August 6, 2018
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-67546

Recalled Products

Contrave Tablet (Extended Release)

Reason

The bottles of affected lots could be perforated.

Depth of distribution

Retailers

Affected products

Contrave Tablet (Extended Release)

DIN, NPN, DIN-HIM

DIN 02472945

Dosage form

Tablet (Extended Release)

Strength

Bupropion hydrochloride 90mg
Naltrexone hydrochloride 8mg

Lot or serial number

ZNPZ, ZNSC

Companies
Recalling Firm

Valeant Canada LP

2150 St-Elzear Boulevard West,

Laval

H7L 4A8

Quebec

CANADA

Marketing Authorization Holder

Valeant Canada LP

2150 St-Elzear Boulevard West,

Laval

H7L 4A8

Quebec

CANADA